Literature DB >> 23740000

Comments on Duran et al.'s systematic review of anticholinergic risk scales (EJCP 2DOI 10.1007/s00228-013-1499-3).

Unax Lertxundi, Saioa Domingo-Echaburu, Borja Ruiz-Osante, Rafael Hernandez Palacios, Javier Peral Aguirregoitia, Juan Medrano Albeniz.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23740000     DOI: 10.1007/s00228-013-1535-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

1.  Systematic review of anticholinergic risk scales in older adults. Response to letter of the editor.

Authors:  Carlos E Durán; Majda Azermai; Robert Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2013-06-06       Impact factor: 2.953

2.  Expert-based drug lists to measure anticholinergic burden: similar names, different results.

Authors:  Unax Lertxundi; Saioa Domingo-Echaburu; Rafael Hernandez; Javier Peral; Juan Medrano
Journal:  Psychogeriatrics       Date:  2013-03       Impact factor: 2.440

  2 in total
  3 in total

1.  Anticholinergic burden in Parkinson's disease inpatients.

Authors:  Unax Lertxundi; Arantxazu Isla; Maria Angeles Solinis; Saioa Domingo-Echaburu; Rafael Hernandez; Javier Peral-Aguirregoitia; Juan Medrano
Journal:  Eur J Clin Pharmacol       Date:  2015-08-09       Impact factor: 2.953

2.  Anticholinergic Drugs and Oral Health-related Quality of Life in Patients with Schizophrenia: A Pilot Study.

Authors:  Justine Chapuis; Francesca Siu-Paredes; Claire Pavageau; Gilles Amador; Nathalie Rude; Frédéric Denis
Journal:  Transl Neurosci       Date:  2020-02-11       Impact factor: 1.757

3.  Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.

Authors:  James A G Crispo; Allison W Willis; Dylan P Thibault; Yannick Fortin; Harlen D Hays; Douglas S McNair; Lise M Bjerre; Dafna E Kohen; Santiago Perez-Lloret; Donald R Mattison; Daniel Krewski
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.